跳至主要内容
临床试验/NCT02085759
NCT02085759已完成不适用

Th2 Cytokine Responses in Overweight/Obese Subjects

West Penn Allegheny Health System1 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2009年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
46
试验地点
1
主要终点
Th2 Cytokine levels

研究概览

简要总结

Cytokines are chemicals that are naturally made by your body. Certain cytokine levels are changed in the blood of patients who develop allergies and/or asthma. Cytokine levels may also be changed in some individuals who are overweight or obese. The purpose of this study is to determine if certain cytokine levels differ based on a person's weight and whether or not they have allergies or asthma. Information gathered in this study will be compared to information gathered from subjects who have participated in another similar study for patients who have allergies and/or asthma.

详细描述

The aims of this study are to:

  1. Characterize the relationship between BMI and Th2 skewing in non-atopic adult subjects.
  2. Compare these results to those previously obtained from atopic adult subjects It is expected that the results of this study will demonstrate enhanced Th2 skewing in overweight and obese atopic subjects as compared to non-atopic subjects. It is further anticipated that the results of this study will be used as preliminary data to generate an NIH grant application exploring the link between obesity and atopy.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • adults aged 18 to 50 years
  • pre-bronchodilator FEV1 > 80% predicted with no evidence of reversibility following administration of bronchodilator
  • no history of allergies

排除标准

  • medical history consistent with atopy and/or asthma
  • any positive response to allergy skin testing for inhalant allergens (defined as a wheal > 3 mm larger than the negative control)
  • a pre-bronchodilator FEV1 < 80% predicted
  • > 12% reversibility in FEV1 following administration of a bronchodilator
  • any history of significant chronic illness
  • history of respiratory infection within the past 2 weeks
  • any use of prescription medications other than oral contraceptives or thyroid hormone replacement within the past 2 months
  • use of any investigational medication within the past month

结局指标

主要结局

Th2 Cytokine levels

时间窗: Baseline (only visit)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David Skoner, MD

Director, Allergy and Asthma Institute

West Penn Allegheny Health System

研究点 (1)

Loading locations...

相似试验